39056911000001101: Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\UK product\Virtual medicinal product\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\UK product\Trade family\Zercepac\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1648671000001117 Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1648681000001115 Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Is a	Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Is a	Zercepac	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has specific active ingredient	Trastuzumab	true	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	false	Inferred relationship	Existential restriction modifier
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial	Has AMP	True	Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1648671000001117	Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1648681000001115	Zercepac 150mg powder for concentrate for solution for infusion vials (Accord Healthcare Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module